{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:18:22Z","timestamp":1759331902209,"version":"3.41.2"},"reference-count":35,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Science and Technology Program Project of Jiangxi Provincial Administration of Traditional Chinese Medicine","award":["2024B1433"],"award-info":[{"award-number":["2024B1433"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n               <jats:title>Objective<\/jats:title>\n               <jats:p>Building upon the established role of P21 Activated Kinase 6 (PAK6) in tumor progression and chemoresistance pathways, we postulate its potential as a dual-function biomarker for small cell lung cancer (SCLC). This investigation aims to conduct a comprehensive evaluation of PAK6\u2019s diagnostic validity and prognostic significance through comparative analysis of PAK6 serological levels across distinct clinical cohorts to determine diagnostic thresholds, and its clinical correlation with therapeutic responsiveness.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Patients and Methods<\/jats:title>\n               <jats:p>This study included 109 patients diagnosed with SCLC, 92 patients with non-small cell lung cancer (NSCLC), 85 patients with pulmonary nodules (PN), and 94 healthy individuals undergoing routine physical examinations as the normal control group (NC). Serum PAK6 concentrations were measured using enzyme-linked immunosorbent assay (ELISA). Additionally, levels of neuron-specific enolase (NSE), carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), and pro-gastrin-releasing peptide (ProGRP) were quantified <jats:italic>via<\/jats:italic> chemiluminescence assays. Progression-free survival (PFS) data for SCLC patients were collected through case review and telephone follow-up.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Results<\/jats:title>\n               <jats:p>Serum PAK6 levels were significantly higher in the SCLC group compared to the other three groups (<jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.01). Similarly, NSE and ProGRP levels were markedly elevated in the SCLC group compared to the other groups (<jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.01). Correlation analysis revealed a positive association between PAK6 and variables such as gender, VA (Veteran\u2019s Administration Lung Cancer Study Group) stage, age, smoking status, CEA, CA19-9, NSE, and ProGRP. The serum tumor markers (STMs) PAK6, NSE, and ProGRP exhibited superior diagnostic performance, with AUCs of 0.892, 0.834, and 0.935, respectively (95% confidence interval (CI) [0.857\u20130.927], [0.778\u20130.890], and [0.909\u20130.960]), compared to CEA and CA19-9 (AUCs = 0.676 and 0.611, respectively; 95% CI [0.622\u20130.731] and [0.547\u20130.675]) (<jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.01). Furthermore, PAK6, NSE, and ProGRP levels significantly decreased after three months of treatment, while CEA and CA19-9 showed no significant changes. Survival analysis demonstrated that higher PAK6 levels were associated with poorer SCLC prognosis. Increased serum PAK6 expression correlated with shorter PFS (HR = 2.02 [1.33\u20133.07], <jats:italic>P<\/jats:italic>\u00a0=\u00a00.001).<\/jats:p>\n            <\/jats:sec>\n            <jats:sec>\n               <jats:title>Conclusion<\/jats:title>\n               <jats:p>Serum PAK6 holds significant clinical value for the diagnosis, treatment monitoring, and prognosis evaluation of SCLC and may serve as a potential therapeutic target for the disease.<\/jats:p>\n            <\/jats:sec>","DOI":"10.7717\/peerj.19714","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T08:30:21Z","timestamp":1753086621000},"page":"e19714","source":"Crossref","is-referenced-by-count":1,"title":["P21 activated kinase 6: a promising tool for predicting small cell lung cancer diagnosis and treatment response"],"prefix":"10.7717","volume":"13","author":[{"given":"Simei","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Blood Transfusion, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kexin","family":"Han","sequence":"additional","affiliation":[{"name":"School of Public Health, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinyi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinlu","family":"Sun","sequence":"additional","affiliation":[{"name":"School of Public Health, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion, The Second Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Ninth Hospital of Nanchang, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4443","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"10.7717\/peerj.19714\/ref-1","doi-asserted-by":"publisher","first-page":"e2400032","DOI":"10.1200\/oa-24-00032","article-title":"Molecular characterization and clinical outcomes of pancreatic neuroendocrine neoplasms harboring PAK4-NAMPT alterations","volume":"2","author":"Azar","year":"2025","journal-title":"Journal of Clinical Oncology"},{"key":"10.7717\/peerj.19714\/ref-2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s12032-023-02246-9","article-title":"Identification of hub genes to determine drug-disease correlation in breast carcinomas","volume":"41","author":"Bhowmick","year":"2023","journal-title":"Medical Oncology"},{"key":"10.7717\/peerj.19714\/ref-3","doi-asserted-by":"publisher","first-page":"e70065","DOI":"10.1111\/jcmm.70065","article-title":"Ethanol extract of Vanilla planifolia stems reduces PAK6 expression and induces cell death in glioblastoma cells","volume":"28","author":"Chang","year":"2024","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.7717\/peerj.19714\/ref-4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.18632\/oncotarget.2803","article-title":"PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"10.7717\/peerj.19714\/ref-5","doi-asserted-by":"publisher","first-page":"20220038","DOI":"10.1002\/VIW.20220038","article-title":"Advanced mass spectrometric and spectroscopic methods coupled with machine learning for in vitro diagnosis","volume":"4","author":"Chen","year":"2023","journal-title":"View"},{"key":"10.7717\/peerj.19714\/ref-6","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1016\/j.ygeno.2020.01.016","article-title":"Systemic analysis of the expression and prognostic significance of PAKs in breast cancer","volume":"112","author":"Dang","year":"2020","journal-title":"Genomics"},{"key":"10.7717\/peerj.19714\/ref-7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"European Journal of Cancer"},{"key":"10.7717\/peerj.19714\/ref-8","doi-asserted-by":"publisher","first-page":"16107","DOI":"10.1073\/pnas.1214447109","article-title":"Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate","volume":"109","author":"Ha","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.7717\/peerj.19714\/ref-9","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41419-022-05118-8","article-title":"PAK6 promotes homologous-recombination to enhance chemoresistance to oxaliplatin through ATR\/CHK1 signaling in gastric cancer","volume":"13","author":"Huang","year":"2022","journal-title":"Cell Death & Disease"},{"key":"10.7717\/peerj.19714\/ref-10","doi-asserted-by":"publisher","first-page":"7655","DOI":"10.3390\/jcm12247655","article-title":"Predictive performance of neuron-specific enolase (NSE) for survival after resuscitation from cardiac arrest: a systematic review and meta-analysis","volume":"12","author":"Kurek","year":"2023","journal-title":"Journal of Clinical Medicine"},{"key":"10.7717\/peerj.19714\/ref-11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1210\/mend.16.1.0753","article-title":"AR and ER interaction with a p21-activated kinase (PAK6)","volume":"16","author":"Lee","year":"2002","journal-title":"Molecular Endocrinology"},{"key":"10.7717\/peerj.19714\/ref-12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12935-022-02689-6","article-title":"Comprehensive analysis of the prognostic implications and functional exploration of PAK gene family in human cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Cancer Cell International"},{"key":"10.7717\/peerj.19714\/ref-13","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"Leiter","year":"2023","journal-title":"Nature Reviews Clinical Oncology"},{"key":"10.7717\/peerj.19714\/ref-14","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.3390\/cancers14194736","article-title":"p21-activated kinase: role in gastrointestinal cancer and beyond","volume":"14","author":"Li","year":"2022","journal-title":"Cancers"},{"key":"10.7717\/peerj.19714\/ref-15","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1074\/jbc.M112.384289","article-title":"p21-activated kinase 6 (PAK6) inhibits prostate cancer growth via phosphorylation of androgen receptor and tumorigenic E3 ligase murine double minute-2 (Mdm2)","volume":"288","author":"Liu","year":"2013","journal-title":"Journal of Biological Chemistry"},{"key":"10.7717\/peerj.19714\/ref-16","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1111\/1759-7714.15075","article-title":"AMPAR receptor inhibitors suppress proliferation of human small cell lung cancer cell lines","volume":"14","author":"Masumoto","year":"2023","journal-title":"Thoracic Cancer"},{"key":"10.7717\/peerj.19714\/ref-17","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3322\/caac.21785","article-title":"Clinical insights into small cell lung cancer: tumor heterogeneity, diagnosis, therapy, and future directions","volume":"73","author":"Megyesfalvi","year":"2023","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.7717\/peerj.19714\/ref-18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.clinbiochem.2004.05.007","article-title":"ProGRP: a new biomarker for small cell lung cancer","volume":"37","author":"Molina","year":"2004","journal-title":"Clinical Biochemistry"},{"key":"10.7717\/peerj.19714\/ref-19","doi-asserted-by":"publisher","first-page":"S219","DOI":"10.3233\/tub-230016","article-title":"Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission","volume":"46","author":"Muley","year":"2024","journal-title":"Tumour Biology"},{"key":"10.7717\/peerj.19714\/ref-20","doi-asserted-by":"publisher","first-page":"111233","DOI":"10.1016\/j.cellsig.2024.111233","article-title":"PAK6 acts downstream of IQGAP3 to promote contractility in triple negative breast cancer cells","volume":"121","author":"Pipili","year":"2024","journal-title":"Cellular Signalling"},{"key":"10.7717\/peerj.19714\/ref-21","doi-asserted-by":"publisher","first-page":"61229","DOI":"10.18632\/oncotarget.11310","article-title":"Chronic exposure to cigarette smoke leads to activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small cell lung cancer cells","volume":"7","author":"Raja","year":"2016","journal-title":"Oncotarget"},{"key":"10.7717\/peerj.19714\/ref-22","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.3390\/cancers13081753","article-title":"Incidence and survival outcomes in patients with lung neuroendocrine neoplasms in the United States","volume":"13","author":"Shah","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.7717\/peerj.19714\/ref-23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/15353702221142614","article-title":"The value of serum TRAP1 in diagnosing small cell lung cancer and tumor immunity","volume":"248","author":"Tan","year":"2023","journal-title":"Experimental Biology and Medicine"},{"key":"10.7717\/peerj.19714\/ref-24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jtho.2022.10.002","article-title":"SCLC: epidemiology, risk factors, genetic susceptibility, molecular pathology, screening, and early detection","volume":"18","author":"Wang","year":"2023","journal-title":"Journal of Thoracic Oncology"},{"key":"10.7717\/peerj.19714\/ref-25","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41893-024-01323-9","article-title":"A sustainable approach to universal metabolic cancer diagnosis","volume":"7","author":"Wang","year":"2024","journal-title":"Nature Sustainability"},{"key":"10.7717\/peerj.19714\/ref-26","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.urology.2008.09.041","article-title":"Knockdown of p21-activated kinase 6 inhibits prostate cancer growth and enhances chemosensitivity to docetaxel","volume":"73","author":"Wen","year":"2009","journal-title":"Urology"},{"key":"10.7717\/peerj.19714\/ref-27","doi-asserted-by":"publisher","first-page":"116557","DOI":"10.1016\/j.bcp.2024.116557","article-title":"Isovalerylspiramycin I suppresses small cell lung cancer proliferation via ATR\/CHK1 mediated DNA damage response and PERK\/eIF2\u03b1\/ATF4\/CHOP mediated ER stress","volume":"230","author":"Xu","year":"2024","journal-title":"Biochemical Pharmacology"},{"key":"10.7717\/peerj.19714\/ref-28","doi-asserted-by":"publisher","first-page":"15345","DOI":"10.1074\/jbc.M010311200","article-title":"Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6","volume":"276","author":"Yang","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.7717\/peerj.19714\/ref-29","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.3892\/ol.2020.11797","article-title":"PAK6 promotes cervical cancer progression through activation of the Wnt\/\u03b2-catenin signaling pathway","volume":"20","author":"Yang","year":"2020","journal-title":"Oncology Letters"},{"key":"10.7717\/peerj.19714\/ref-30","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1182\/bloodadvances.2023011512","article-title":"Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes","volume":"8","author":"Yao","year":"2024","journal-title":"Blood Advances"},{"key":"10.7717\/peerj.19714\/ref-31","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12672-024-01323-3","article-title":"A comparative study of ProGRP and CEA as serological markers in small cell lung cancer treatment","volume":"15","author":"Yu","year":"2024","journal-title":"Discover Oncology"},{"key":"10.7717\/peerj.19714\/ref-32","doi-asserted-by":"publisher","first-page":"101039","DOI":"10.1016\/j.tranon.2021.101039","article-title":"Neuron specific enolase promotes tumor metastasis by activating the Wnt\/\u03b2-catenin pathway in small cell lung cancer","volume":"14","author":"Zha","year":"2021","journal-title":"Translational Oncology"},{"key":"10.7717\/peerj.19714\/ref-33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2147\/ott.S444396","article-title":"Prognostic factors and construction of nomogram prediction model of lung cancer patients using clinical and blood laboratory parameters","volume":"17","author":"Zhang","year":"2024","journal-title":"OncoTargets and Therapy"},{"key":"10.7717\/peerj.19714\/ref-34","doi-asserted-by":"publisher","first-page":"118888","DOI":"10.1016\/j.bbamcr.2020.118888","article-title":"p21-activated kinase 6 controls mitosis and hepatocellular carcinoma progression by regulating Eg5","volume":"1868","author":"Zheng","year":"2021","journal-title":"Biochimica et Biophysica Acta: Molecular Cell Research"},{"key":"10.7717\/peerj.19714\/ref-35","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s12094-017-1617-2","article-title":"Neuron-specific enolase and response to initial therapy are important prognostic factors in patients with small cell lung cancer","volume":"19","author":"Zhou","year":"2017","journal-title":"Clinical and Translational Oncology"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/19714.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/19714.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/19714.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/19714.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T08:30:22Z","timestamp":1753086622000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/19714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":35,"alternative-id":["10.7717\/peerj.19714"],"URL":"https:\/\/doi.org\/10.7717\/peerj.19714","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"type":"electronic","value":"2167-8359"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"article-number":"e19714"}}